Cefazolin Injection, Solution
Product Images NDC 0338-0096

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 0338-0096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefazolin Sodium, Usp Structural Formula.jpg (Image 01)

Chemical structure of cefazolin sodium, displaying its molecular components including multiple ring structures and functional groups characteristic of this antibiotic compound.*

FDA Label Image

Representative Cefazolin Container Label 0338-3503-41 1 Of 2 (Image 02)

Label for Cefazolin Injection, USP 2 g/100 mL (20 mg/mL) intravenous injection solution. The single-dose container is labeled under Baxter Healthcare Corporation and features usage instructions, storage conditions, and dosage information. The product is distributed under the Galaxy brand, with specific warnings regarding storage temperature and handling.*

FDA Label Image

Representative Cefazolin Container Label 0338-3503-41 2 Of 2 (Image 03)

Label panel featuring a vertically oriented barcode with accompanying numbers and text stating 'BAR CODE POSITION ONLY UPC-A'. No other product details or branding are visible in the image.*

FDA Label Image

Representative Cefazolin Carton Label 0338-3503-41 1 Of 2 (Image 04)

Cefazolin Injection, USP 2 g/100 mL (20 mg/mL) intravenous solution label by Baxter Healthcare Corporation. The label states it contains 6 units of Single-Dose bags, with each bag containing 100 mL. It includes storage instructions to keep the product at or below -20°C (-4°F) and warnings against freezing by immersion in water baths or microwave irradiation. The label displays the NDC 0338-3508-41 and a barcode positioning note.*

FDA Label Image

Representative Cefazolin Carton Label 0338-3503-41 2 Of 2 (Image 05)

Cefazolin 2 g/100 mL intravenous injection solution label from Baxter Healthcare Corporation. The label notes the product is a sterile nonpyrogenic solution containing 2 g of Cefazolin USP per 100 mL, adjusted with Sodium bicarbonate, sodium hydroxide, or hydrochloric acid. It states use for intravenous infusion only and includes manufacturer and trademark information for Baxter.*

FDA Label Image

Representative Cefazolin Container Label 0338-3508-41 1 Of 2 (Image 06)

A text panel showing placeholder information for a drug label, including fields for code, lot number, expiration date, quantity, and serial number, repeated twice side-by-side. Each section contains the phrase 'FOR PLACEMENT ONLY' inside a box and various placeholder alphanumeric strings beneath, indicating it is a template or sample label content for printing purposes.*

FDA Label Image

Representative Cefazolin Container Label 0338-3508-41 2 Of 2 (Image 07)

Label for Cefazolin Injection, USP 1 g/50 mL (20 mg/mL) injection solution by Baxter Healthcare Corporation. The label states it is a single-dose container with each 50 mL containing 1 g of Cefazolin, USP. It includes storage instructions, usage indication for intravenous infusion, and cautions regarding thawing and reuse. The label shows NDC 0338-3503-41 and lot number Gz3503.*

FDA Label Image

Representative Cefazolin Carton Label 0338-3508-41 1 Of 2 (Image 08)

A barcode label reading "BAR CODE POSITION ONLY" with the numeric code 303383503411. The label appears to be a printed sticker likely used for placing a barcode on packaging or documentation. There is no other product information visible in this image.*

FDA Label Image

Representative Cefazolin Carton Label 0338-3508-41 1 Of 2 (Image 09)

Packaging labels for Baxter Healthcare Corporation's Cefazolin Injection, USP, 1 g/50 mL (20 mg/mL) intravenous solution. The labels show a 12-pack of 50 mL single-dose containers with iso-osmotic solution, instructions to store at or below -20°C (-4°F) without refreezing, and various storage and handling warnings. The NDC codes 0338-3503-41 and 0338-3503-03 and lot codes G23503 and G23503 are visible, along with a note to thaw at room temperature or under refrigeration and not to force thaw by immersion or microwave.*

FDA Label Image

Representative Cefazolin Container Label 0338-0096-06 1 Of 2 (Image 10)

Drug facts text panel for Cefazolin Injection Solution, displaying formulation information for 1 g Cefazolin USP per 50 mL in a GALAXY container. The panel includes concentration details, pH adjustment information, usage notes for intravenous infusion, and warnings against adding other medications or using if the solution is not clear. It also advises discarding the bag if the integrity is compromised.*

FDA Label Image

Representative Cefazolin Container Label 0338-0096-06 2 Of 2 (Image 11)

A text panel containing placeholder data fields for CODE, LOT, EXP, QTY, and SN, repeated twice side-by-side. Each section includes a box labeled 'FOR PLACEMENT ONLY' and lines of obscured alphanumeric text. The bottom right corner shows a numeric code '07-06-77-680'.*

FDA Label Image

Representative Cefazolin Carton Label 0338-0096-06 1 Of 2 (Image 12)

Labels for Cefazolin in Dextrose Injection, USP 3 g/150 mL solution for intravenous use. Each label states prescription use only and instructs proper thawing and storage, including not to force thaw or refreeze and to store at or below -20°C. The labeler is not explicitly mentioned on the image but product data confirms Baxter Healthcare Corporation.*

FDA Label Image

Representative Cefazolin Carton Label 0338-0096-06 2 Of 2 (Image 13)

Label for Cefazolin injection solution, 3 g/150 mL, intravenous use. The label indicates the product as sterile, nonpyrogenic, containing 3 g Cefazolin USP equivalent to 3.15 g Cefazolin Sodium USP, plus approx. 6 g Dextrose Hydrous USP and Water for Injection USP. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA. Includes dosage caution and barcode placement area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.